SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-130076
Filing Date
2020-11-27
Accepted
2020-11-27 17:08:15
Documents
1
Period of Report
2020-11-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2037145-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2037145-4_4seq1.xml 4 4591
  Complete submission text file 0001104659-20-130076.txt   6107
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KIRKLAND & ELLIS LLP 300 NORTH LASALLE CHICAGO IL 60654
Business Address
Singer William S. (Reporting) CIK: 0001617927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 201355824